Erratum: Efficient and scalable precision genome editing in staphylococcus aureus through conditional recombineering and CRISPR/Cas9-mediated counterselection (mBio, (2018) 9, 1, 10.1128/mBio.00067-18);Efficient and scalable precision genome editing in Staphylococcus aureus through conditional recombineering and CRISPR/Cas9-mediated counterselection

mBio

Volumn 9, Issue 1, 2018, Pages

  Penewit, Kelsi ^a   Holmes, Elizabeth A ^a   McLean, Kathyrn ^a   Ren, Mingxin ^b   Waalkes, Adam ^a   Salipante, Stephen J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b University of Washington   (United States)

Author keywords

Cas9; CRISPR; Genetic engineering; Genome editing; MutS; Recombineering; Staphylococcus aureus

Indexed keywords

CRISPR ASSOCIATED PROTEIN; PROTEIN EF2132; RECOMBINASE; SINGLE STRANDED DNA; SYNTHETIC DNA; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM ISOLATION; BACTERIUM TRANSFORMATION; ELECTROPORATION; ENTEROCOCCUS FAECALIS; FUNCTIONAL ASSESSMENT; GENE DELETION; GENE EDITING; GENE FUNCTION; GENETIC ENGINEERING; GENETIC VARIATION; NONHUMAN; PHENOTYPE; POINT MUTATION; POPULATION GENETICS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TEMPERATURE SENSITIVITY; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENETIC RECOMBINATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PROCEDURES; STAPHYLOCOCCUS INFECTION;

CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-ASSOCIATED PROTEIN 9; GENE EDITING; HUMANS; RECOMBINASES; RECOMBINATION, GENETIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 85043490455     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02698-18     Document Type: Erratum

References (67)

1. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK; Active Bacterial Core surveillance (ABCs) MRSA Investigators. 2007. Invasive methicillin-resistant Staphylo- coccus aureus infections in the United States. JAMA 298:1763–1771. https://doi.org/10.1001/jama.298.15.1763.
2. Wertheim HFL, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JAJW, van Keulen PHJ, Vandenbroucke-Grauls CMJE, Meester MHM, Verbrugh HA. 2004. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364:703–705. https://doi.org/10.1016/S0140-6736(04)16897-9.
3. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J. Rybak M, Talan DA, Chambers HF. 2011. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52:285–292. https://doi.org/10.1093/cid/cir034.
4. Lowy FD. 1998. Staphylococcus aureus infections. N Engl J Med 339: 520–532. https://doi.org/10.1056/NEJM199808203390806.
5. Conlon BP. 2014. Staphylococcus aureus chronic and relapsing infections: evidence of a role for persister cells: an investigation of persister cells, their formation and their role in S. aureus disease. Bioessays 36:991–996. https://doi.org/10.1002/bies.201400080.
6. Ahmed MI, Mukherjee S. 2016. Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis. Cochrane Database Syst Rev 3:CD011581. https://doi.org/10.1002/14651858.CD011581.pub2.
7. McAdam PR, Holmes A, Templeton KE, Fitzgerald JR. 2011. Adaptive evolution of Staphylococcus aureus during chronic endobronchial infection of a cystic fibrosis patient. PLoS One 6:e24301. https://doi.org/10.1371/journal.pone.0024301.
8. Shah PL, Mawdsley S, Nash K, Cullinan P, Cole PJ, Wilson R. 1999. Determinants of chronic infection with Staphylococcus aureus in patients with bronchiectasis. Eur Respir J 14:1340–1344. https://doi.org/10.1183/09031936.99.14613409.
9. Cullen L, McClean S. 2015. Bacterial adaptation during chronic respiratory infections. Pathogens 4:66–89. https://doi.org/10.3390/pathogens 4010066.
10. Zecconi A, Scali F. 2013. Staphylococcus aureus virulence factors in evasion from innate immune defenses in human and animal diseases. Immunol Lett 150:12–22. https://doi.org/10.1016/j.imlet.2013.01.004.
11. Powers ME, Bubeck Wardenburg J. 2014. Igniting the fire: Staphylococcus aureus virulence factors in the pathogenesis of sepsis. PLoS Pathog 10:e1003871. https://doi.org/10.1371/journal.ppat.1003871.
12. Oogai Y, Matsuo M, Hashimoto M, Kato F, Sugai M, Komatsuzawa H. 2011. Expression of virulence factors by Staphylococcus aureus grown in serum. Appl Environ Microbiol 77:8097–8105. https://doi.org/10.1128/AEM.05316-11.
13. Gordon CP, Williams P, Chan WC. 2013. Attenuating Staphylococcus aureus virulence gene regulation: a medicinal chemistry perspective. J Med Chem 56:1389–1404. https://doi.org/10.1021/jm3014635.
14. Saïd-Salim B, Dunman PM, McAleese FM, Macapagal D, Murphy E, McNamara PJ, Arvidson S, Foster TJ, Projan SJ, Kreiswirth BN. 2003. Global regulation of Staphylococcus aureus genes by Rot. J Bacteriol 185:610–619. https://doi.org/10.1128/JB.185.2.610-619.2003.
15. Monk IR, Shah IM, Xu M, Tan MW, Foster TJ. 2012. Transforming the untransformable: application of direct transformation to manipulate genetically Staphylococcus aureus and Staphylococcus epidermidis. mBio 3:e00277-11. https://doi.org/10.1128/mBio.00277-11.
16. Monk IR, Tree JJ, Howden BP, Stinear TP, Foster TJ. 2015. Complete bypass of restriction systems for major Staphylococcus aureus lineages. mBio 6:e00308-15. https://doi.org/10.1128/mBio.00308-15.
17. Lindberg M, Sjöström JE, Johansson T. 1972. Transformation of chromosomal and plasmid characters in Staphylococcus aureus. J Bacteriol 109:844–847.
18. Yu D, Zhao L, Xue T, Sun B. 2012. Staphylococcus aureus autoinducer-2 quorum sensing decreases biofilm formation in an icaR-dependent manner. BMC Microbiol 12:288. https://doi.org/10.1186/1471-2180-12-288.
19. Prax M, Lee CY, Bertram R. 2013. An update on the molecular genetics toolbox for staphylococci. Microbiology 159:421–435. https://doi.org/10.1099/mic.0.061705-0.
20. Brückner R. 1997. Gene replacement in Staphylococcus carnosus and Staphylococcus xylosus. FEMS Microbiol Lett 151:1–8.
21. Bae T, Schneewind O. 2006. Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 55:58–63. https://doi.org/10.1016/j.plasmid.2005.05.005.
22. Chen W, Zhang Y, Yeo WS, Bae T, Ji Q. 2017. Rapid and efficient genome editing in Staphylococcus aureus by using an engineered CRISPR/Cas9 system. J Am Chem Soc 139:3790–3795. https://doi.org/10.1021/jacs.6b13317.
23. Liu Q, Jiang Y, Shao L, Yang P, Sun B, Yang S, Chen D. 2017. CRISPR/ Cas9-based efficient genome editing in Staphylococcus aureus. Acta Biochim Biophys Sin 49:764–770. https://doi.org/10.1093/abbs/gmx074.
24. Schneewind O, Missiakas D. 2014. Genetic manipulation of Staphylococcus aureus. Curr Protoc Microbiol 32:Unit 9C.3. https://doi.org/10.1002/9780471729259.mc09c03s32.
25. Datta S, Costantino N, Zhou X, Court DL. 2008. Identification and analysis of recombineering functions from Gram-negative and Gram-positive bacteria and their phages. Proc Natl Acad Sci U S A 105:1626–1631. https://doi.org/10.1073/pnas.0709089105.
26. Selle K, Barrangou R. 2015. Harnessing CRISPR-Cas systems for bacterial genome editing. Trends Microbiol 23:225–232. https://doi.org/10.1016/j.tim.2015.01.008.
27. Jiang W, Bikard D, Cox D, Zhang F, Marraffini LA. 2013. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol 31:233–239. https://doi.org/10.1038/nbt.2508.
28. Huang H, Zheng G, Jiang W, Hu H, Lu Y. 2015. One-step high-efficiency CRISPR/Cas9-mediated genome editing in Streptomyces. Acta Biochim Biophys Sin 47:231–243. https://doi.org/10.1093/abbs/gmv007.
29. Altenbuchner J. 2016. Editing of the Bacillus subtilis genome by the CRISPR-Cas9 system. Appl Environ Microbiol 82:5421–5427. https://doi.org/10.1128/AEM.01453-16.
30. Mougiakos I, Bosma EF, de Vos WM, van Kranenburg R, van der Oost J. 2016. Next generation prokaryotic engineering: the CRISPR-Cas toolkit. Trends Biotechnol 34:575–587. https://doi.org/10.1016/j.tibtech.2016.02.004.
31. Barrangou R, van Pijkeren JP. 2016. Exploiting CRISPR-Cas immune systems for genome editing in bacteria. Curr Opin Biotechnol 37:61–68. https://doi.org/10.1016/j.copbio.2015.10.003.
32. Xu T, Li Y, Shi Z, Hemme CL, Li Y, Zhu Y, Van Nostrand JD, He Z, Zhou J. 2015. Efficient genome editing in Clostridium cellulolyticum via CRISPR-Cas9 nickase. Appl Environ Microbiol 81:4423–4431. https://doi.org/10.1128/AEM.00873-15.
33. Ellis HM, Yu D, DiTizio T, Court DL. 2001. High efficiency mutagenesis, repair, and engineering of chromosomal DNA using single-stranded oligonucleotides. Proc Natl Acad Sci U S A 98:6742–6746. https://doi.org/10.1073/pnas.121164898.
34. Reisch CR, Prather KLJ. 2015. The no-SCAR (Scarless Cas9 Assisted Re-combineering) system for genome editing in Escherichia coli. Sci Rep 5:15096. https://doi.org/10.1038/srep15096.
35. Watanabe Y, Cui L, Katayama Y, Kozue K, Hiramatsu K. 2011. Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus. J Clin Microbiol 49:2680–2684. https://doi.org/10.1128/JCM.02144-10.
36. Charpentier E, Anton AI, Barry P, Alfonso B, Fang Y, Novick RP. 2004. Novel cassette-based shuttle vector system for gram-positive bacteria. Appl Environ Microbiol 70:6076–6085. https://doi.org/10.1128/AEM.70.10.6076-6085.2004.
37. Cowan ST, Shaw C, Williams RE. 1954. Type strain for Staphylococcus aureus Rosenbach. J Gen Microbiol 10:174–176. https://doi.org/10.1099/00221287-10-1-174.
38. Sawitzke JA, Costantino N, Li XT, Thomason LC, Bubunenko M, Court C, Court DL. 2011. Probing cellular processes with oligo-mediated recombination and using the knowledge gained to optimize recombineering. J Mol Biol 407:45–59. https://doi.org/10.1016/j.jmb.2011.01.030.
39. Duthie ES, Lorenz LL. 1952. Staphylococcal coagulase; mode of action and antigenicity. J Gen Microbiol 6:95–107. https://doi.org/10.1099/00221287-6-1-2-95.
40. Kuwahara-Arai K, Kondo N, Hori S, Tateda-Suzuki E, Hiramatsu K. 1996. Suppression of methicillin resistance in a mecA-containing pre-methicillin-resistant Staphylococcus aureus strain is caused by the mecI-mediated repression of PBP 2= production. Antimicrob Agents Chemother 40:2680–2685.
41. Baba T, Bae T, Schneewind O, Takeuchi F, Hiramatsu K. 2008. Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J Bacteriol 190:300–310. https://doi.org/10.1128/JB.01000-07.
42. Soni I, Chakrapani H, Chopra S. 2015. Draft genome sequence of methicillin-sensitive Staphylococcus aureus ATCC 29213. Genome Announc 3:e01095-15.
43. Morikawa K, Takemura AJ, Inose Y, Tsai M, Nguyen Thi le T, Ohta T, Msadek T. 2012. Expression of a cryptic secondary sigma factor gene unveils natural competence for DNA transformation in Staphylococcus aureus. PLoS Pathog 8:e1003003. https://doi.org/10.1371/journal.ppat.1003003.
44. Mosberg JA, Gregg CJ, Lajoie MJ, Wang HH, Church GM. 2012. Improving lambda red genome engineering in Escherichia coli via rational removal of endogenous nucleases. PLoS One 7:e44638. https://doi.org/10.1371/journal.pone.0044638.
45. Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, Lim WA. 2013. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152:1173–1183. https://doi.org/10.1016/j.cell.2013.02.022.
46. Costantino N, Court DL. 2003. Enhanced levels of lambda Red-mediated recombinants in mismatch repair mutants. Proc Natl Acad Sci U S A 100:15748–15753. https://doi.org/10.1073/pnas.2434959100.
47. Denamur E, Matic I. 2006. Evolution of mutation rates in bacteria. Mol Microbiol 60:820–827. https://doi.org/10.1111/j.1365-2958.2006.05150.x.
48. Wang HH, Isaacs FJ, Carr PA, Sun ZZ, Xu G, Forest CR, Church GM. 2009. Programming cells by multiplex genome engineering and accelerated evolution. Nature 460:894–898. https://doi.org/10.1038/nature08187.
49. Helle L, Kull M, Mayer S, Marincola G, Zelder M-E, Goerke C, Wolz C, Bertram R. 2011. Vectors for improved Tet repressor-dependent gradual gene induction or silencing in Staphylococcus aureus. Microbiology 157:3314–3323. https://doi.org/10.1099/mic.0.052548-0.
50. Sun Z, Deng A, Hu T, Wu J, Sun Q, Bai H, Zhang G, Wen T. 2015. A high-efficiency recombineering system with PCR-based ssDNA in Bacillus subtilis mediated by the native phage recombinase GP35. Appl Microbiol Biotechnol 99:5151–5162. https://doi.org/10.1007/s00253-015 -6485-5.
51. Van Pijkeren JP, Neoh KM, Sirias D, Findley AS, Britton RA. 2012. Exploring optimization parameters to increase ssDNA recombineering in Lac-tococcus lactis and Lactobacillus reuteri. Bioengineered 3:209–217. https://doi.org/10.4161/bioe.21049.
52. Thomason LC, Costantino N, Court DL. 2016. Examining a DNA replication requirement for bacteriophage λ Red- and Rac prophage RecET-promoted recombination in Escherichia coli. mBio 7. https://doi.org/10.1128/mBio.01443-16.
53. Wang HH, Xu G, Vonner AJ, Church G. 2011. Modified bases enable high-efficiency oligonucleotide-mediated allelic replacement via mismatch repair evasion. Nucleic Acids Res 39:7336–7347. https://doi.org/10.1093/nar/gkr183.
54. Nyerges Á, Csörgő B, Nagy I, Bálint B, Bihari P, Lázár V, Apjok G, Umenhoffer K, Bogos B, Pósfai G, Pál C. 2016. A highly precise and portable genome engineering method allows comparison of mutational effects across bacterial species. Proc Natl Acad Sci U S A 113:2502–2507. https://doi.org/10.1073/pnas.1520040113.
55. Chen JS, Dagdas YS, Kleinstiver BP, Welch MM, Sousa AA, Harrington LB, Sternberg SH, Joung JK, Yildiz A, Doudna JA. 2017. Enhanced proofreading governs CRISPR-Cas9 targeting accuracy. Nature 550:407–410. https://doi.org/10.1038/nature24268.
56. Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, Makarova KS, Essletzbichler P, Volz SE, Joung J, van der Oost J, Regev A, Koonin EV, Zhang F. 2015. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163:759–771. https://doi.org/10.1016/j.cell.2015.09.038.
57. Kim HK, Song M, Lee J, Menon AV, Jung S, Kang YM, Choi JW, Woo E, Koh HC, Nam JW, Kim H. 2017. In vivo high-throughput profiling of CRISPR-Cpf1 activity. Nat Methods 14:153–159. https://doi.org/10.1038/nmeth.4104.
58. Lee JC. 1995. Electrotransformation of staphylococci. Methods Mol Biol 47:209–216. https://doi.org/10.1385/0-89603-310-4:209.
59. Sau S, Sun J, Lee CY. 1997. Molecular characterization and transcriptional analysis of type 8 capsule genes in Staphylococcus aureus. J Bacteriol 179:1614–1621. https://doi.org/10.1128/jb.179.5.1614-1621.1997.
60. Salipante SJ, Sr, SenGupta DJ, Cummings LA, Land TA, Hoogestraat DR, Cookson BT. 2015. Application of whole-genome sequencing for bacterial strain typing in molecular epidemiology. J Clin Microbiol 53: 1072–1079. https://doi.org/10.1128/JCM.03385-14.
61. Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, Jelsbak L, Sicheritz-Pontén T, Ussery DW, Aarestrup FM, Lund O. 2012. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol 50:1355–1361. https://doi.org/10.1128/JCM.06094-11.
62. Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG. 2004. EBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol 186:1518–1530. https://doi.org/10.1128/JB.186.5.1518-1530.2004.
63. van der Vossen JM, van der Lelie D, Venema G. 1987. Isolation and characterization of Streptococcus cremoris Wg2-specific promoters. Appl Environ Microbiol 53:2452–2457.
64. Corrigan RM, Foster TJ. 2009. An improved tetracycline-inducible expression vector for Staphylococcus aureus. Plasmid 61:126–129. https://doi.org/10.1016/j.plasmid.2008.10.001.
65. Gibson DG, Young L, Chuang RY, Venter JC, Hutchison CA, Smith HO. 2009. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods 6:343–345. https://doi.org/10.1038/nmeth.1318.
66. Donegan NP, Marvin JS, Cheung AL. 2014. Role of adaptor TrfA and ClpPC in controlling levels of SsrA-tagged proteins and antitoxins in Staphylococcus aureus. J Bacteriol 196:4140–4151. https://doi.org/10.1128/JB.02222-14.
67. Moreno-Mateos MA, Vejnar CE, Beaudoin JD, Fernandez JP, Mis EK, Khokha MK, Giraldez AJ. 2015. CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo. Nat Methods 12:982–988. https://doi.org/10.1038/nmeth.3543.